Camilo Molina, MD

Camilo A. Molina, MD

Specializes In
  • Neurosurgery
  • Spine Surgery
Languages Spoken
  • Spanish


Sees Patients For

Complex spine surgery, minimally invasive spine surgery, spinal deformities, spinal oncology, degenerative spine disease, spinal stenosis, spinal trauma.

Hospital Affiliations

  • Barnes-Jewish Hospital
  • Barnes-Jewish West County Hospital



Academic Title(s)

Assistant Professor, Neurosurgery and Orthopedic Surgery
Deputy Director, Spine Innovation, Center for Innovation in Neuroscience and Technology

Research Interests

Dr. Molina is a spine fellowship-trained neurosurgeon with two years of dedicated spine training. He specializes in the entire spectrum of spine disease ranging from large complex multidisciplinary spine surgeries to minimally invasive outpatient spine procedures. He has an active laboratory devoted to the investigation, development, and clinical translation of novel technologies that have the potential of decreasing surgical invasiveness and improving surgical safety, efficacy, and efficiency. His clinical and research vision converges on the mission of providing his patients an avenue to return to their lives in the least disruptive manner. He is an expert and lead developer in novel robotic and augmented reality spine surgery solutions. Dr. Molina was a leader on the clinical design team that ultimately led to the FDA approval and performance of the first augmented reality mediated spine procedures in the United States.

Publications & Research

Search PubMed for publications »


Fellowship: Complex Spine

2020 Johns Hopkins Hospital, Baltimore, MD

Residency: Neurosurgery

2019 Johns Hopkins Hospital, Baltimore, MD

Medical Degree

2013 Johns Hopkins University School of Medicine, Baltimore, MD

Financial Disclosures
  • Augmedics LLC
    • Equity: Yes
    • Reporting Date: 05/01/2022
  • Kinexus
    • Equity: Yes
    • Reporting Date: 05/01/2022
  • Stryker
    • Speaker Fees: $10,000 - $19,999
    • Reporting Date: 05/01/2022

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.